Page 13 - WJOLS - Laparoscopic Journal

WJOLS

Sleeve Gastrectomy in Metabolic Syndrome for Nonmorbid Obese Patients: Is this the Future for Diabetes Treatment?

Table 2: Total weight loss (kg) Table 3: Body mass index reduction overall
Patient Initial 6 Months 12 Months Total weight loss Percentage BMI reduction
1 45.45 38.18 27.49 17.96 39.52 Patient Initial 6 Months Final
2 35.54 28.79 22.45 13.08 36.82 1 30.86 25.93 22.22
3 38.22 30.96 26.94 11.29 29.53 2 27.70 22.44 21.61
4 35.95 29.12 21.84 14.11 39.25 3 30.52 28.08 26.55
5 35.54 28.43 21.61 13.93 39.20 4 30.89 25.02 23.17
24.13
22.92
30.16
5
6 32.64 28.07 23.02 9.62 29.48 6 25.45 21.88 20.87
7 33.47 30.79 25.87 7.60 22.72 7 26.40 24.29 22.18
8 38.22 30.88 20.07 18.15 47.48 8 29.10 23.57 18.91
9 40.91 31.09 21.76 19.15 46.80 9 31.51 23.95 22.06
10 38.22 34.02 28.92 9.31 24.35 10 29.79 26.52 25.32
Mean 37.42 31.03 24.00 13.42 35.87 Mean 29.24 24.58 22.58

Graph 3: Mean BMI reduction overall Graph 5: Lipids improvement overall after 12 months

One patient had gastric leak that was observed and
treated with drainage and had to continue with special
nutritional support and clinical evaluation during
3 weeks.
CONCLUSION

The MS was diagnosed in 10 patients according to the
NCEP-ATP III definition. And the overall outcome of
the patients was that 90% of the patients had less than three
criteria out of five described to diagnose MS. The total
temporary remission without medication of DM was
achieved in 60% and no patient suffered from malabsorp-
tion complications or went underweight. The overall BMI
reduction for nonobese patients with sleeve gastrectomy
Graph 4: Body mass index and HbAI decrease over 12 months
period after sleeve gastrectomy was 22.6 Kg/m² and the minimum achieved by one
patient was 18.91 Kg/m² without complications and with
a mean of 200.5 to 98.5 mg/dl, and mean HDL raised an adequate nutritional evaluation and support. There
from 39.3 to 47.20 mg/dl (Graph 5). From the 80% of is still a lot of information to be gathered, and it would
the patients that had hypertension, blood pressure had make the surgical knowledge even wider, to make
normalized (< 140/90 mm Hg) in 90% of the patients international general consensus about the procedures, pro-
without hypertension treatment. Only one patient cesses and variables to be analyzed and measured during the
continued with oral medication for hypertension and DM surgical treatment of nonobese metabolic patients. But the
but had improvement in the overall clinical evaluation. data gathered so far, indicate that performing a restrictive,
World Journal of Laparoscopic Surgery, September-December 2015;8(3):75-80 79